Candidiasis – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Candidiasis – Drugs In Development, 2024 report and make more profitable business decisions.
Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. A Candida infection of the skin appears as a clearly defined patch of red, itchy skin, often leaking fluid. Scabs and pustules may be seen around the edge of the rash. It will usually be found in areas such as the groin; the folds of the buttocks; between the breasts, toes, or fingers; and in the navel. Treatment includes antifungal drugs.
The Candidiasis drugs in development market research report provide comprehensive information on the therapeutics under development for Candidiasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Candidiasis and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Candidiasis | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 73 molecules, with 57 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Candidiasis therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Candidiasis pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Candidiasis treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
60 Degrees Pharmaceuticals IncAbGenics Life Sciences Pvt Ltd
AimMax Therapeutics Inc
Autoimmune Technologies LLC
Bakker Medical Srl
Basilea Pharmaceutica Ltd
Beta Pharma Inc
Biocidium Biopharmaceuticals Inc
Biokawthar Technologies SAS
Biomendics LLC
Biosergen AS
Cidara Therapeutics Inc
Cincinnati Children's Hospital Medical Center
Cisen Pharmaceutical Co Ltd
Concerto Biosciences Inc
CSPC Pharmaceutical Group Ltd
Dare Bioscience Inc
Destiny Pharma Plc
Female Healthcare Purna
Gedeon Richter Plc
General Biologicals Corp
Georgetown University
Grupo Ferrer Internacional SA
HC Synthetic Pharmaceutical Co Ltd
Jiangsu Hengrui Medicine Co Ltd
Jiangsu ProteLight Pharmaceutical & Biotechnology Co Ltd
Kansas State University
King's College London
Louisiana State University Health Sciences Center New Orleans
Matinas BioPharma Holdings Inc
MicroRid Technologies Inc
Mycovia Pharmaceuticals Inc
Nanomerics Ltd
Next Science Ltd
Nosopharm SAS
Oryn Therapeutics
Osel Inc
Pacgen Life Science Corp
Pfizer Inc
Profem GmbH
Profounda Inc
Pulmocide Ltd
Pulmonomy Inc
R-Pharm
REYON Pharmaceutical Co Ltd
Riptide Bioscience Inc
Sano Chemicals Inc
SaNOtize Research and Development Corp
Satellos Bioscience Inc
Scynexis Inc
Second Military Medical University
Stadius Biopharma LLC
State University of New York at Buffalo
Stony Brook University
The Lundquist Institute
Toltec Pharmaceuticals LLC
University of Aberdeen
University of Toulouse
University of Wisconsin Madison
Wellstat Vaccines LLC
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Candidiasis reports